These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab. Benson DM, Smith MK, Krugh D, Devine SM. Bone Marrow Transplant; 2008 Mar; 41(6):595-6. PubMed ID: 18037934 [No Abstract] [Full Text] [Related]
6. Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease. Furlong T, Leisenring W, Storb R, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K, Kiem HP, Nash RA, Sanders JE, Witherspoon R, Thompson D, Martin PJ. Biol Blood Marrow Transplant; 2002 Mar; 8(4):206-12. PubMed ID: 12014809 [Abstract] [Full Text] [Related]